Who we are
Our capabilities
Thanks to our technical expertise, our state-of-the-art industrial tools and our regulatory skills, we offer standard products or customized solutions to support our customers’ innovations.
Our historical activity of high precision plastic transformation, true DNA of SGH Medical Pharma, is enriched by complementary know-how.
Product and process engineering
We imagine and develop new solutions to enhance your success.
Manufacturing and supply management
We are constantly improving our industrial and logistical tools, on all our production sites, to anticipate your needs, with the permanent objective of reducing our environmental impact.
Regulatory compliance
We provide the expertise of our teams to ensure that, from product development to marketing, you comply with all pharmaceutical and medical international standards and requirements to which they are subject.
Our values
Innovation
We rely on the perfection of our processes to innovate and design usuable applicable medical devices, with a global technological vision and a sustainable-ethical approach.
Agility
Multisite and responsive, we are commited to maintaining this innovative mindset, no matter the circumstances and requests, with the added capacity to deliver.
Willingness
Everything is possible. Thanks to the “doing together” approach, our teams are mobilized to go ever further, for more useful innovations, product performance and customer innovation in respect of the environment.
Strategy
The aim of SGH Medical Pharma’s ambitious development project is to build a European group, specialising mainly in drug administration, respiratory conditions and diagnotics.
SGH Medical Pharma is aiming for turnover of €100 million, which will enable it to reach the critical mass sought by our laboratory customers and manage the structural costs associated with regulatory requirements. I attach critical importance to compliance with laws, regulations and universal ethical principles. Our corporate social responsibility policy reflects our commitment through the rules and ethical principles it supports and protects, and to which it is actively committed.
Promoting this culture and demanding compliance is, in our view, essential: we must be able to guarantee that we always act with integrity.
We will therefore increase our turnover alongside, the organisation’s clear desire to incorporate social and environmental considerations into its decision-making but we will also well equipped to account for the impact of its decisions and activities on society and the environment.
Our story
-
1984
The ROVIP GROUP diversifies its business in healthcare, in a new entity to become ROVIPHARM
-
1985
Creation of STIPLASTICS
-
1995
Creation of ESKISS
-
2003
STIPLASTICS and ROVIP both get ISO 13485
-
2006
Creation of ROVIPHARM
-
2017
STIPLASTICS builds a new 10,000m² manufacturing plant in Saint-Marcellin
-
2018
Creation of SGH HEALTHCARING, reuniting STIPLASTICS, ESKISS and ROVIPHARM
Involvment of Merieux Equity Partners and GIMV
-
2019
Shift towards IVD with first strategic agreements as a Contract Manufacturer
IQ DOSE gets a Pharmapack Award
-
2021
New ISO 8-7, DNA RNA free, 100% automated cleanroom on the ROVIPHARM site
-
2022
First filtered pipette tips production batches
SGH Healthcaring becomes SGH MEDICAL PHARMA
-
2023
New cleanroom
-
2024
STIPLASTICS site will become a Pharmaceutical Establishment
600m² plant extension
Locations
Wheter you are looking for an existing product or you want to develop a specific one, our 250 employees spread over 4 different sites are dedicated to help inject you success.
Tour Oxygène
10 – 12 Boulevard Vivier Merle
69003 Lyon, France
62 chemin des Plantées
38160 Saint-Marcellin, France
Tel. : +33 4 76 38 08 44
86 route du Plan d’eau
01370 Val-Revermont, France
Tel. : +33 4 74 42 39 39
Parc Naturopôle
03800 Saint-Bonnet-de-Rochefort, France
Tel. : +33 4 70 58 85 51
